Epigenetic Transgenerational Actions of Endocrine Disruptors and Male Fertility by Anway, Matthew D. et al.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Faculty Papers and Publications in Animal 
Science Animal Science Department 
June 2005 
Epigenetic Transgenerational Actions of Endocrine Disruptors and 
Male Fertility 
Matthew D. Anway 
Washington State University, Pullman 
Andrea S. Cupp 
University of Nebraska-Lincoln, acupp2@unl.edu 
Mehmet Uzumcu 
Rutgers University 
Michael K. Skinner 
Washington State University, Pullman 
Follow this and additional works at: https://digitalcommons.unl.edu/animalscifacpub 
 Part of the Animal Sciences Commons 
Anway, Matthew D.; Cupp, Andrea S.; Uzumcu, Mehmet; and Skinner, Michael K., "Epigenetic 
Transgenerational Actions of Endocrine Disruptors and Male Fertility" (2005). Faculty Papers and 
Publications in Animal Science. 169. 
https://digitalcommons.unl.edu/animalscifacpub/169 
This Article is brought to you for free and open access by the Animal Science Department at 
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Faculty Papers and 
Publications in Animal Science by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. 
Treatments, such as irradiation and che-
motherapy, and compounds, such as environ-
mental toxins, pose a threat to the integrity of 
the genome. Studies have shown that these 
agents can result in genetic or developmen-
tal defects in the offspring or F1 generation
 
from an exposed gestating mother. The abil-
ity of an external agent to induce a transgen-
erational effect requires stable chromosomal 
alterations or an epigenetic phenomenon such 
as DNA methylation (1). In the present study, 
transgenerational refers to a germline trans-
mission to multiple generations, minimally to 
the F2 generation.
 Transgenerational effects 
of irradiation were the first to be identified 
through transmission of DNA mutations in 
the germ line to multiple generations (2), of-
ten associated with tumor formation. Chemo-
therapeutic treatments (3) and environmen-
tal toxins such as endocrine disruptors (4) can 
cause effects in the F1 generation, but they 
have not been shown to affect the F2 gener-
ation. Although no effects have been shown 
to be transgenerational, the potential impact 
of such transgenerational effects of endocrine 
disruptors has been discussed (5). 
Epigenetic alterations that could lead to 
transgenerational transmission of specific ge-
netic traits have recently been identified (1, 
6). A transgenerational phenotype or genetic 
trait requires a permanent reprogramming 
of the germ line. During mammalian germ 
cell development the methylation state of 
the genome is reprogrammed. As primordial 
germ cells (PGCs) migrate down the genital 
ridge, a demethylation starts and is com-
plete on colonization in the early gonad (7, 
8). Germ cells in the gonad then undergo re-
methylation in a sex-specific manner during 
gonadal sex determination (9). Although de-
methylation may not require the gonadal so-
matic cells, remethylation of the germ line 
appears to be dependent on association with 
the somatic cells in the gonads (7). Gonadal 
sex determination and testis development 
occur between embryonic days 12 and 15 
(E12 to E15) in the rat (after midgestation in 
the human) and are initiated by the differen-
tiation of precursor Sertoli cells in response 
to the testis-determining factor Sry. Aggre-
gation of the precursor Sertoli cells, PGCs, 
and migrating mesonephros cells (precur-
sor peritubular myoid cells) promotes tes-
tis morphogenesis and cord formation (10, 
11). During the period of gonadal sex deter-
mination, the fetal testis contains steroid re-
ceptors and is a target for endocrine agents. 
The androgen receptor (AR) and estrogen 
receptor–β (ERβ) are present in Sertoli cells, 
precursor peritubular myoid cells, and germ 
cells at the time of cord formation (E14) 
(12, 13). Although steroids are not produced 
by the testis at this stage of development, es-
trogenic and androgenic substances have the 
ability to influence early testis cellular func-
tions. Therefore, steroidal factors acting in-
appropriately at the time of gonadal sex de-
termination potentially could reprogram 
the germ line through an epigenetic mecha-
nism (altered DNA methylation) to cause the 
transgenerational transmission of an altered 
phenotype or genetic trait. 
The estrogenic and antiandrogenic endo-
crine disruptors used in the current study are 
methoxychlor and vinclozolin, respectively. 
Vinclozolin is a commonly used fungicide 
in the wine industry that is metabolized into 
more active (i.e., higher affinity binding to an-
drogen receptor) compounds (14). Methoxy-
chlor is used as a pesticide to replace DDT 
and is metabolized into active compounds 
with the ERα agonist, the ERβ antagonist, and 
anti-androgenic activity (15–17). Vinclozolin 
or methoxychlor exposure in the late embry-
onic or early postnatal period influences sex-
ual differentiation, gonad formation, and re-
productive functions in the F1 generation (14, 
18, 19). Transient exposure (daily intraper-
itoneal injection of 100 or 200 mg/kg dose) 
of a gestating female rat to methoxychlor or 
vinclozolin between E8 and E15 promotes 
reduced spermatogenic capacity associated 
with increased spermatogenic cell apoptosis 
and decreased sperm number and motility in 
the adult F1 generation (20, 21). A similar ex-
posure between E15 and E20 had no effect on 
the F1 generation testis
 (20, 21). These obser-
vations were extended in the present study by 
treating the gestating mother with vinclozo-
lin. F1 generation
 male rats were mated with 
F1 generation females from different
 litters. 
Subsequent breeding continued for four gen-
erations with sufficient numbers of animals to 
avoid sibling inbreeding. Adult males from 
F1, F2, F3, and F4 generations between post-
natal days PND60 and PND180 were killed. 
Testes were isolated for histological exam-
ination, and caudal epididymal sperm were 
collected for sperm counts and motility mea-
surements. Only the original gestating mother 
(F0) of the F1 generation received a transient
 
endocrine disruptor treatment. Control groups 
of animals were bred in a similar manner af-
ter vehicle treatment (dimethylsulfoxide buf-
fer alone injected) of the F0 gestating mother. 
Analysis of cellular apoptosis demonstrated 
a greater than two-fold increase in spermato-
genic cell apoptosis in the vinclozolin treat-
ment animals for the F1 to F4 generations 
(Figure 1A). Sperm numbers were reduced 
minimally, 20%, and sperm forward motility 
was reduced about 25 to 35% for vinclozolin 
generation animals (Figure 1, B and C). More 
than 90% of all males analyzed from all gen-
erations had the germ cell defect of increased 
spermatogenic cell apoptosis. Therefore, the 
frequency of the phenotype was >90% and 
did not decline between the F1 and F4 gener-
ations. A similar experiment was performed 
with methoxychlor. After transient embryonic 
methoxychlor exposure (E8 to E15), a similar 
phenotype was observed in both the F1 and F2 
animals (fig. S1). Therefore, both vinclozolin 
and methoxychlor induced transgenerational 
defects in spermatogenic capacity and sperm 
viability. 
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Abstract
Transgenerational effects of environmental toxins require either a chromosomal or epigenetic 
alteration in the germ line. Transient exposure of a gestating female rat during the period 
of gonadal sex determination to the endocrine disruptors vinclozolin (an antiandrogenic 
compound) or methoxychlor (an estrogenic compound) induced an adult phenotype in the 
F1 generation of decreased
 spermatogenic capacity (cell number and viability) and increased 
incidence of male infertility. These effects were transferred through the male germ line to 
nearly all males of all subsequent generations examined (that is, F1 to F4). The effects on 
reproduction correlate with altered DNA methylation patterns in the germ line. The ability 
of an environmental factor (for example, endocrine disruptor) to reprogram the germ line 
and to promote a transgenerational disease state has significant implications for evolutionary 
biology and disease etiology.
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An outcross experiment was performed to 
determine whether the transgenerational phe-
notype was transmitted through the male germ 
line. Vinclozolin F2 generation males (i.e., 
male progeny from an F0 treated mother) were 
crossed with wild-type untreated control fe-
males, and the offspring were analyzed. The 
vinclozolin outcross (VOC) male progeny also 
had an increase in spermatogenic cell apopto-
sis and a decrease in sperm number and mo-
tility (Figure 1). The reverse vinclozolin out-
cross (RVOC) with vinclozolin F2 generation 
females and wild-type control males demon-
strated no effect on the spermatogenic cells 
(Figure 1). Therefore, the endocrine disruptor–
induced transgenerational phenotype appears 
to be transmitted through the male germ line. 
The morphology of the testes from con-
trol and treated rats was similar for all ani-
mals examined on PND60 in all F1 to F4 vin-
clozolin generations. Periodically, male rats 
older than 90 days of age developed com-
plete infertility associated with small testis 
and severely reduced spermatogenesis, which 
was not seen in the PND60 animals. This oc-
curred in 4 out of a total of 50 F1,
 F2, F3, and 
F4 generation animals. Therefore, 8% of the 
vinclozolin transgenerational males devel-
oped complete infertility. None of the 42 con-
trol F1 to F4 generation animals were infer-
tile. The testis histology for a representative 
infertile vinclozolin F3 generation animal is 
shown in Figure 2 and demonstrates a loss of 
normal spermatogenesis (no germ cells pres-
ent) and abnormal seminiferous tubule mor-
phology. The control F3 male showed normal
 
morphology with normal spermatogenesis. 
Although most of the animals older than 90 
days of age were fertile, 20% developed a 
dramatic decrease in spermatogenic capac-
ity (50% of the tubules having impaired germ 
cell development) in all the generations ex-
amined. The VOC males also had increased 
infertility in 20% of the animals over 90 
days of age. The treated males that were fer-
tile showed no change in litter size, new-
born pup weights, or testis weight per body 
weight when compared with the control ani-
mals of any of the F1 to F4 generations exam-
ined. Nearly all the treated male progeny had 
the minimal phenotype of twofold increase in 
spermatogenic cell apoptosis, and the major-
ity had a decrease in epididymal sperm num-
ber (Figure 1, A and B). 
 The transmission of this endocrine dis-
ruptor–induced testis phenotype in a trans-
generational manner suggests an epigenetic 
alteration of the male germ line. The fre-
quency observed for the phenotype (>90% 
of all males in all generations) cannot be ex-
plained through genetic DNA sequence mu-
tational mechanisms. A high-frequency ge-
netic (DNA sequence) mutation hotspot event 
would be an order of magnitude less than that 
observed (2, 22, 23). Subsequent segregation 
of this mutation would likely result in a re-
duction of the phenotype frequency with each 
generation. In addition, the random nature of 
genetic (DNA sequence) mutations is gener-
ally more variable in the phenotype observed 
(2, 22, 23). In contrast, an epigenetic mech-
anism involving reprogramming of the germ 
line could result in the high frequency ob-
served. In addition, the developmental period 
used for the endocrine disruptor exposure 
was during the remethylation programming 
of the germ line. Although we cannot exclude 
the possibility of a novel genetic (DNA se-
quence) mutational event, available informa-
tion suggests an epigenetic mechanism is in-
volved. 
 
Figure 1. Transgenerational phenotype after 
vinclozolin treatment of F0 gestating mothers. 
(A) Spermatogenic cell apoptosis, (B) epidid-
ymal sperm counts, and (C) epididymal sperm 
motility in PND60 to 180 control and vinclozo-
lin off-spring Sprague-Dawley rats in the F1, 
F2, F3, and F4 generations, and vinclozolin F2 
generation male outcross (VOC) to wild-type 
control females, and vinclozolin F2 generation 
female reverse outcross (RVOC) to wild-type 
control males. Statistically significant differ-
ences between control and vinclozolin treat-
ment generations are indicated by (*) for P < 
0.001 with a two-way analysis of variance test. 
The n value for each bar ranged between 10 
and 30 animals. Detailed methods are pro-
vided in Supporting Materials (below). 
Figure 2. Testis histology 
from control (A) and vinclo-
zolin treatment (B) 100-day-
old F3 generation animals, × 
200 magnification. The vin-
clozolin F3 generation male 
is a representative infertile 
male. Arrow in (A) identifies 
the tails of elongate sper-
matozoa in the seminiferous 
tubule lumen; arrowhead la-
bels spermatocytes in the 
tubule epithelial layer. Ar-
row in (B) identifies the lack 
of germ cells in the seminif-
erous tubule. Methods are 
provided in Supporting Ma-
terials (below).
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The only epigenetic mechanism currently 
known to influence germline transmission in-
volves the methylation pattern of imprinted 
genes. This study does not investigate spe-
cific known imprinted genes, but focuses on 
the effects of the endocrine disruptor on the 
total genome. Fisher rats were used because 
of reduced polymorphisms, which made 
methylation studies more consistent and re-
producible. PND6 testes were collected from 
male F1 progeny of vinclozolin-treated
 and 
control rats. A methylation-sensitive restric-
tion enzyme digestion analysis involving a 
polymerase chain reaction (PCR)–based pro-
cedure was used to assess changes in DNA 
methylation patterns (Methods in SOM). An-
imals (n = 4) from different litters of control 
and treated animals were analyzed. The vin-
clozolin-induced methylation patterns were 
similar in the replicate animals. About 25 dif-
ferent PCR products were identified that had 
altered DNA methylation patterns after the 
endocrine disruptor treatment. A representa-
tive change in methylation pattern is shown 
in Figure 3A and fig. S2. These methylation 
experiments were extended by isolating and 
cloning several of the DNA fragments with 
apparent altered methylation. Two of the 
DNA fragments were sequenced and mapped 
to CpG-rich regions on chromosomes 6q32 
and 8q32 (Figure 3B). Clone 7 mapped to 
6q32 and was within the lysophospholi-
pase (LPLase) gene (accession NM144750). 
LPLase is a critical enzyme in the synthe-
sis of important bioactive lipids and associ-
ated signaling (24). Clone 17 mapped to 8q32 
and is within 1 kb of the start site of an un-
characterized protein termed cytokine-induc-
ible SH2 protein (accession AJ243907 [Gen-
Bank]). Whether the genes identified are 
causal factors or simply markers (i.e., down-
stream) of the transgenerational epigenetic 
pheno-type remains to be determined. 
The epigenetic transgenerational trans-
mission of the altered methylation pattern 
through the male germ line was investigated. 
PCR primers were designed for the flanking 
regions of the clone 17 gene, cytokine-induc-
ible SH2 protein and were used to investigate 
altered methylation with the methylation-sen-
sitive restriction enzyme digest procedure. 
Epididymal sperm were isolated from vinclo-
zolin treatment F2 and F3 generation animals. 
As shown in Figure 3C, the control animals 
had the PCR product, whereas the vinclozo-
lin treatment F2 and F3 animals did not. The 
control Rsa I digest had a PCR product in all 
samples. Therefore, the vinclozolin treatment 
F2 and F3 generation sperm samples appeared
 
to have altered DNA methylation in this clone 
17 gene compared with control animal sperm. 
An alternate bisulfite DNA sequence analysis 
was used to confirm the methylation changes. 
Bisulfite analysis confirmed the altered meth-
ylations of the LPLase gene within the CpG 
island identified. This bisulfite altered se-
quence (fig. S3) was observed in ~25% of 
the vinclozolin treatment sperm DNA sam-
ples analyzed. A single-gene methylation 
event alone is not likely sufficient to promote 
the phenotype, but could cause alterations in 
a subset of genes. For example, 25 DNA se-
quences with altered methylation were iden-
tified, and if a random subset of genes with 
altered methylation promotes the phenotype, 
a 25% frequency for altered methylation of 
a single gene would be significant. Observa-
tions indicate that the endocrine disruptors 
can induce an epigenetic transgenerational 
change in the DNA methylation pattern of 
the male germ line. The epigenetic alterations 
observed involve both hypermethylation and 
hypomethylation events. 
Two different endocrine disruptors, vin-
clozolin and methoxychlor, after a transient 
embryonic exposure at a critical time dur-
ing gonadal sex determination (E8 to E15 
in the rat), promoted an adult testis pheno-
type of decreased spermatogenic capacity 
and male infertility. No gross abnormality 
was observed in any other tissues examined, 
and serum testosterone levels were found to 
be normal in all the animals examined. This 
phenotype was found to be transgenerational 
and appears associated with altered DNA 
methylation of the male germ line. The phe-
notype was observed in nearly all males 
from all vinclozolin generations, such that 
a genetic mutation event (e.g., alteration in 
DNA sequence) is not likely to be a major 
factor. The frequency of a genetic mutation 
would be orders of magnitude less than the 
transmission frequency observed in the cur-
rent study (2, 22, 23). Preliminary data dem-
onstrate no major effect on the female, but 
a number of abnormal pregnancy outcomes 
were observed in pregnant females from off-
spring of vinclozolin-treated animals, but 
not controls. The abnormal phenotype has 
similarities to preeclampsia that include 
death, severe anemia, and blood cell defects. 
This study shows that environmental factors 
can induce an epigenetic transgenerational 
phenotype through an apparent reprogram-
ming of the male germ line. It should be 
noted that the exposure levels used in these 
studies are higher than anticipated for envi-
ronmental exposure; hence, future toxicol-
ogy studies would be needed to ascertain the 
possible impact on animal populations. 
Figure 3. DNA methylation analysis from control and vinclozolin offspring testis. (A) Representative gel images of the PCR-based methylation-sensi-
tive Hpa II restriction enzyme digest analysis with representative band (arrow) affected in PND6 testis from control and vinclozolin treatment animals. 
Each lane represents a different individual animal (n = 4). (B) Location of selected sequences on specific chromosomes for two representative DNA 
sequences with altered DNA methylation patterns termed clone 7 and 17. (C) Methylation-sensitive restriction enzyme PCR analysis of the methyla-
tion state of clone 17 (i.e., cytokine-inducible SH2 protein) gene in epididymal sperm from F2 and F3 generations from control and vinclozolin-treated 
animals. The bands presented are representative of sperm DNA collected from different animals from different litters and are consistent in four out of 
eight F2 animals and two out of five F3 animals analyzed. Methods are provided in Supporting Materials (below).
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MATERIALS & METHODS
A. In Vivo Procedures
Gestating outbred Sprague-Dawley and inbred Fisher mother rats from timed pregnant
colonies housed at the Washington State University Vivarium were given intraperitoneal
injections of vinclozolin (100 mg/kg per day) and methoxychlor (200 mg/kg/day) from
embryonic day 8-15 (E8-E15) of gestation (F0 generation) as previously described (S1).
Sperm positive vaginal smear date being embryonic day 0. Gestating control mothers
received vehicle alone (i.e. sesame oil or DMSO). At least 6 lines (individual F0 injected
females) were generated for controls and treated groups for these analyses. Male rats from
control and treated groups were collected at P60-P180 for analyses. F1 treated males were
bred to F1 treated females to generate the F2 treated generation and F2 treated males were
bred to F2 treated females to generate the F3 generation and the F3 were bred in the same
manner to generate the F4 generation. Rats for the control groups were bred in the same
manner for all the generations. No inbreeding or sibling crosses were generated. The
outcross group (VOC) was generated by breeding the F2 treated males with wild-type
females (total of 6 litters) and reverse outcross group (RVOC) was generated by breeding
F2 treated females with wild-type males (total of 3 litters). Control (n = 4) and treated (n =
4) male offspring from the F1 generation from Fisher strain rats were collected at P6 for
DNA methylation analysis, see below. All procedures have been approved by the
Washington State University Animal Use and Care Committee. The numbers of animals
used for replicates in the experiments (i.e., n value) for vinclozolin treatment are as
follows: F1 (control 11, treated 12); F2 (control 19, treated 30); F3 (control 19, treated 26);
F4 (control 15, treated 21); outcrosses (VOC 18, RVOC 6, wild-type controls 8). The
methoxychlor treatment animal number was for F1 (control 6, treated 9) and F2 (control 16,
treated 22).
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B. Sperm Motility and Concentration Analysis
Animals were sacrificed and cauda epididymal sperm motility was determined using
cauda epididymal sperm. Briefly, the epididymis was dissected free of connective tissue
and a small cut made to the cauda. The tissue was placed in 5 ml of culture medium
containing 0.1% BSA for 10 min at 37°C. An aliquot was placed on a pre-warmed slide
and gently cover-slipped. The specimen was immediately examined using phase contrast
microscopy with 100x magnification. All the motile sperm (i.e rapid progressive, slow
progressive, and non-progressive) were counted according to WHO category (S2). Percent
ratio of the motile sperm to the total number of sperm including immotile sperm was
calculated. Epididymal sperm count was determined using the same epididymis sample
according to a previously described method with some modifications (S3).
C. Histology
Tissues were fixed in Bouin’s (Sigma, St. Louis, MO), embedded in paraffin, sectioned
and then sections stained with hematoxylin and eosin according to standard procedures.
The Center for Reproductive Biology, Histology Core Laboratory assisted with these
procedures. The animal numbers are n = 50 for vinclozolin treatment and n = 42 for
controls.
D. Detection of Cell Apoptosis
To detect apoptotic cells in testis sections, the Fluorescein In Situ Cell Death Detection
Kit (Roche Applied Science, Indianapolis, IN) was utilized (S1). This system measures the
fragmented DNA from apoptotic cells by enzymatically incorporating fluorecein-12-dUTP
at the 3’-OH DNA ends using the enzyme terminal deoxynucleotidyl transferase which
forms a polymeric tail using the principle of the TUNEL assay. Fluorescent apoptotic cells
were imaged on a confocal microscope and number of apoptotic cells per testis cross
section determined. A minimum of n = 8 for vinclozolin and n = 6 for controls for each
generation was used. All cross sections used for TUNEL analysis had normal testis
morphology.
E. DNA Methylation Assays
The methylation status of DNA isolated from control and endocrine disruptor treated P6
testis or epididymal sperm was determined using a combination of methylation sensitive
restriction enzymes and a PCR approach previously described (S4, S5). Briefly, isolated
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genomic DNA was incubated and digested with Rsa I with either methylation-sensitive
(Hpa II) or insensitive (Msp I) restriction enzymes, followed by PCR with 10 primer sets
designed to amplify methylation sites. PCR products were electrophoretically separated
and visualized by SYBR green staining (Molecular Probes, Eugene, OR) and effects of
endocrine disruptors determined by the presence or absence of specific bands. The PCR
products of interest were isolated, cloned and sequenced to determine chromosomal
location using BLAST Genbank analysis (S6, S7). P6 testis analysis was repeated using 4
animals from different litters.
F. Bisulfite Sequencing
Genomic DNA was isolated from F1-F4 sperm samples using the DNeasy Tissue Kit
(Qiagen, Valencia, CA) and digested with Rsa I. Genomic DNA was then treated with
sodium bisulfite following methods previously established (S8). Briefly, 5 µg of digested
DNA was denatured in NaOH then treated with 4.0 M sodium metabisulfite pH 5.0 for 16
hours at 55°C. Following desalting, DNA was desulfonated with NaOH, neutralized and
precipitated with ammonium acetate and ethanol. DNA samples were resuspended in 30
µL of 1mM Tris buffer, pH 8.0. Sequence specific primers were generated to amplify the
region of interest. PCR products were cloned into pGEMT Easy vector (Promega
Corporation) and sequenced. Approximately 35 clones from each PCR product were
sequenced to determine the methylation state of the CpG sites. Confirming altered
methylation states involved comparisons of the sequences following the bisulfite
treatment. The primers for the lysophospholipase PCR bisulfite analysis were 5’GGT
ATA TAT AGA GGA AGG TAG GTA GG3’ and 5’TAA AAA CCT CCA AAA AAC
AAA CAC T3’.
G. Statistical Analysis
The data from apoptotic cell numbers, sperm motility and sperm count were analyzed
using a SAS program. The values were expressed as the mean ± SEM. Statistical analysis
was performed and the difference between the means of treatments and respective controls
was determined using two-way Analysis of Variance (ANOVA). Analysis performed with
JMP v3.1.6, SAS Institute Inc, Cary, NC. In vivo experiments were repeated with 6-30
individuals for each data point. A statistically significant difference was confirmed at P <
0.05.
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Fig. S1. Transgenerational phenotype after methoxychlor treatment. (A) Spermatogenic cell apoptosis. (B)
epididymal sperm counts. (C) Epididymal sperm motility in P60-P120 control and treated Fisher rats in F1
and F2 generations. Statistically significantly differences between control and treated animals within a
generation are indicated by (*) for P < 0.05. The number of animals for each bar ranged between 6 and 12.
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